BlackRock Inc. - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 35 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$153,810
-6.2%
439,456
-0.0%
0.00%
Q3 2022$164,000
-18.8%
439,641
-0.1%
0.00%
Q2 2022$202,000
-27.1%
439,928
-20.8%
0.00%
Q1 2022$277,000
-13.4%
555,397
-1.0%
0.00%
Q4 2021$320,000
-44.1%
560,968
+1.1%
0.00%
Q3 2021$572,000
-14.4%
554,683
-0.4%
0.00%
Q2 2021$668,000
-18.8%
556,900
-12.1%
0.00%
Q1 2021$823,000
-62.8%
633,435
+5.1%
0.00%
Q4 2020$2,211,000
+71.4%
602,436
-0.0%
0.00%
Q3 2020$1,290,000
+19.1%
602,712
-0.3%
0.00%
Q2 2020$1,083,000
+40.6%
604,529
+3.6%
0.00%
Q1 2020$770,000
-27.6%
583,519
-0.1%
0.00%
Q4 2019$1,063,000
-37.1%
584,394
-0.1%
0.00%
Q3 2019$1,691,000
+7.7%
584,899
-0.5%
0.00%
Q2 2019$1,570,000
-57.3%
587,973
-59.2%
0.00%
Q1 2019$3,675,000
-10.2%
1,440,905
-2.5%
0.00%
Q4 2018$4,094,000
-68.5%
1,478,231
+1.3%
0.00%
-100.0%
Q3 2018$13,000,0001,459,1850.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
Palo Alto Investors LP 77,044$283,0000.02%
683 Capital Management, LLC 88,470$325,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders